GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › LH growth analysis
Growth stock analysis · updated 2026-07-27

Labcorp Holdings Inc. (LH) growth stock analysis

Is Labcorp Holdings Inc. a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Partly. LH is a mixed case
69
Growth score
64
RS rating
#573
Rank
3/6
Traits passed
69/99
Growth score · 573rd of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about LH

As of the 2026-07-27 close, LH scores 69 out of 99 on our growth-stock rating, a mixed growth-stock profile. That ranks it 573rd of 4,897 rated US stocks, the top 12% of the market.

Its strongest trait is N (new highs & catalysts) at 93, and its weakest is A (annual earnings growth) at 29. LH clears 3 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, LH carries a middling Relative Strength rating of 64, meaning it has outperformed about 64% of the market over the past year.

Underneath the score: quarterly earnings up 33% year over year, sales up 6%, trading at a fresh 52-week high.

LH growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
73
A
Annual earnings growth
multi-year earnings trend
29
N
New highs & catalysts
proximity to new 52-week highs
93
S
Supply & demand
volume behind the move vs. share supply
44
L
Leader or laggard
Relative Strength within its group
61
I
Institutional sponsorship
fund accumulation and 13F ownership
55

Is LH a growth stock?

Partly. LH is a mixed case

LH passes some CANSLIM traits but not others. The letter breakdown above shows exactly where it holds up and where it falls short.

🔒 Stronger growth stocks than LH

The stocks ranking above LH today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 LH price history & buy range

Where LH sits in its base, its 52-week path, and the trait trend over the past year.

Open the full LH profile →

See where LH ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

LH as a growth stock, frequently asked

Is LH a good growth stock?

Partly. LH is a mixed case. LH passes some CANSLIM traits but not others. The letter breakdown above shows exactly where it holds up and where it falls short.

What is LH's growth score?

Labcorp Holdings Inc. (LH) scores 69 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 573rd of 4,897 rated US stocks.

Does LH have strong earnings growth?

LH's most recent quarterly earnings were up about 33% year over year, with sales up 6%.

How strong is LH's price performance?

LH has a Relative Strength rating of 64, meaning it has outperformed roughly 64% of the US market over the trailing year.

Where can I see LH's full analysis?

Create a free Growth Stock Analyzer account to see where LH ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Services-Medical Laboratories